S&P 500 Consumer Staples Sector SEC Filings — October 15, 2026

Full-year 2026 outlook reaffirmed with mid-single-digit constant-currency Adjusted Operating Profit growth and high-single-digit Adjusted EPS growth from continuing operations, indicating underlying earnings momentum despite top-line headwinds

Organic sales expected ~100 bps below weighted average category growth (~1.7% TTM), with China social media disruption already realized and potentially more to come, a clear share-loss signal in a key market

Guidance for a low-single-digit constant-currency decline in Adjusted EPS Attributable to Kimberly-Clark, despite growth in continuing-operations EPS, implies margin and earnings dilution from the Suzano JV or transaction-related items that investors should quantify before November 5

Outlook explicitly excludes the pending Kenvue Acquisition, so the reaffirmation does not yet price in deal financing, synergy, or integration costs, making the guidance a floor-type rather than fully-loaded view

Q3 and nine-month final results scheduled for November 5, 2026, with a 6:30 a.m. EST release and 8:00 a.m. EST Q&A, a near-term catalyst to test whether the reaffirmed outlook holds

CFO Bhumbla Ash received an award of 62,468 common shares and now holds 62,468 shares post-transaction; this is a compensation grant with no open-market purchase or sale, so it carries no conviction signal either way

Company growth tracking ~100 bps behind category growth shows relative underperformance in the current period, which should be weighed against any valuation discount when comparing staples peers

China social media disruptions have already impacted results, with ~100 bps of realized and potential unfavorable organic sales impact still unresolved and no quantified recovery timeline

Adjusted EPS Attributable to Kimberly-Clark guided to a low-single-digit constant-currency decline while continuing-operations Adjusted EPS grows high-single-digit, a gap of roughly 10 percentage points that suggests significant attributable-earnings dilution

Pending acquisition is excluded from outlook, creating execution, financing, and dilution risk that could materially change guidance once the deal closes or its terms are finalized

International Family Care and Professional joint venture with Suzano is excluded from guidance, leaving the timing, accounting, and earnings contribution of the JV unquantified

Forward-looking non-GAAP figures are not reconciled to GAAP because unpredictable adjustment items could be material, reducing visibility into true reported earnings

Outlook excludes potential acquisitions, divestitures, and unidentified items, meaning reported results could diverge meaningfully from guidance

Q3 2026 figures are preliminary and unaudited, so final November 5 results may revise the reaffirmed outlook

Reaffirmed high-single-digit continuing-operations Adjusted EPS growth and mid-single-digit Adjusted Operating Profit growth could support a re-rating if the November 5 print confirms the outlook and clarifies the attributable-earnings bridge

Completion of the Kenvue Acquisition, if it closes on terms consistent with strategy, could create scale and cost-synergy upside not yet reflected in the excluded outlook

The ~100 bps China headwind is described as realized and potential, so a stabilization of social media disruption would represent recoverable organic growth versus category trends

The International Family Care and Professional joint venture could add earnings and international footprint once consolidated, offering upside relative to the excluded baseline

The November 5 Q&A session is a near-term venue to resolve the attributable-EPS decline question, which could remove a key overhang for the stock

Routine equity grants to the CFO that are not paired with open-market sales are generally a neutral-to-mildly-positive alignment signal; monitor for subsequent Form 4 purchases as a stronger conviction indicator

Kimberly-Clark's disclosure of ~100 bps of organic sales drag from China social media disruption points to a channel-specific risk that may affect other personal care and household brands selling heavily through digital commerce into China, with implications for peer growth comparisons

Kimberly-Clark's outlook excludes both the pending Kenvue Acquisition and the Suzano JV, illustrating that large portfolio reshaping in staples is increasingly leaving headline guidance partially disconnected from reported results, raising the importance of pro forma disclosure

Weighted average category growth of ~1.7% TTM provides a useful baseline for judging organic performance, and Kimberly-Clark's tracking ~100 bps below it indicates staples leaders are facing sub-2% underlying category growth, pressuring top-line leverage across the sector

Both the Kimberly-Clark outlook and its emphasis on constant-currency metrics show continued reliance on currency-neutral framing, which investors should normalize against when comparing staples companies with different FX exposure

The available insider activity in this stream is limited to a routine executive equity award at Hormel, consistent with compensation-driven rather than conviction-driven insider flows across staples names during this period

Final results and Q&A on November 5, 2026 (press release ~6:30 a.m. EST, Q&A 8:00 a.m. EST); watch whether the attributable-EPS decline guidance holds and how China disruption is quantified

Monitor deal timing, financing structure, and any updates to pro forma guidance once the transaction is more definitive

Watch for closing timing and accounting treatment to reconcile the gap between continuing-operations and attributable Adjusted EPS

Track any further disclosure on the ~100 bps impact and whether the drag is expanding or stabilizing

Monitor subsequent Form 4 filings for open-market purchases or sales that would provide a stronger conviction signal than the routine award

Watch peer disclosures for whether category growth is accelerating or decelerating, as it frames organic-growth comparisons across the sector